Prescription Drug Monitoring Programs: Promising Practices in Need of Refinement

被引：15

|

作者：

Compton, Wilson M. ^{[1
,2
]}

Wargo, Eric M. ^{[1
]}

机构：

[1] NIDA, 6001 Execut Blvd, Bethesda, MD 20892 USA

[2] 6001 Execut Blvd,MSC 9581, Bethesda, MD 20892 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2018年 / 168卷 / 11期

关键词：

UNITED-STATES; HEROIN;

D O I：

10.7326/M18-0883

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：826 / +

页数：3

相关论文

共 50 条

[1] Prescription Drug Monitoring Programs Serve a Vital Clinical Need
Fishman, Scott M.
PAIN MEDICINE, 2011, 12 (06) : 845 - 845
[2] Evaluation of Australian prescription drug monitoring programs need a holistic approach
Haines, Sarah
Prathivadi, Pallavi
AUSTRALIAN JOURNAL OF PRIMARY HEALTH, 2021, 27 (05) : 354 - 356
[3] Prescription drug monitoring programs
Miller, Michael M.
Brown, Randall T.
AMERICAN FAMILY PHYSICIAN, 2007, 75 (06) : 810 - 811
[4] Prescription Drug Monitoring Programs Combating prescription drug misuse
Gudoski, Anthony J.
NURSE PRACTITIONER, 2015, 40 (11): : 28 - 33
[5] What do PAs need to know about prescription drug monitoring programs?
Mospan, Geoffrey A.
Lucas, Austin
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2017, 30 (07): : 11 - 12
[6] Prescription Drug Monitoring Programs and Drug Overdoses
不详
PHARMACEUTICAL MEDICINE, 2018, 32 (04) : 304 - 304
[7] Prescription Drug Monitoring Programs and drug overdoses
Reactions Weekly, 2018, 1702 (1) : 9 - 9
[8] The evolution of prescription drug monitoring programs
Ashburn, Michael A.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (07) : 852 - 853
[9] Privacy and Prescription Drug Monitoring Programs
Vivian, Jesse C.
US PHARMACIST, 2014, 39 (05) : 44 - 46
[10] Prescription Drug Monitoring Programs Reply
Gugelmann, Hallam M.
Perrone, Jeanmarie
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (09): : 912 - 913

← 1 2 3 4 5 →